Dr. Raymond C Wadlow, MD
Claim this profileInova Schar Cancer Institute
Area of expertise
Pancreatic Cancer
Raymond C Wadlow, MD has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Pancreatic Carcinoma
Raymond C Wadlow, MD has run 2 trials for Pancreatic Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Inova Schar Cancer Institute
Inova Fairfax Hospital
Clinical Trials Raymond C Wadlow, MD is currently running
Early Detection
for Pancreatic Cancer
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Recruiting
1 award
N/A
10 criteria
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting
4 awards
Phase 3
18 criteria
More about Raymond C Wadlow, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Raymond C Wadlow, MD has experience with
- Oxaliplatin
- Pembrolizumab
- LSTA1
- Quality-of-Life Assessment
- Endoscopic Ultrasound
- Computed Tomography
Breakdown of trials Raymond C Wadlow, MD has run
Pancreatic Cancer
Pancreatic Carcinoma
Pancreatic Adenocarcinoma
Colorectal Cancer
Rectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raymond C Wadlow, MD specialize in?
Raymond C Wadlow, MD focuses on Pancreatic Cancer and Pancreatic Carcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Raymond C Wadlow, MD currently recruiting for clinical trials?
Yes, Raymond C Wadlow, MD is currently recruiting for 2 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Raymond C Wadlow, MD has studied deeply?
Yes, Raymond C Wadlow, MD has studied treatments such as Oxaliplatin, Pembrolizumab, LSTA1.
What is the best way to schedule an appointment with Raymond C Wadlow, MD?
Apply for one of the trials that Raymond C Wadlow, MD is conducting.
What is the office address of Raymond C Wadlow, MD?
The office of Raymond C Wadlow, MD is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.